Last reviewed · How we verify
NCT07418242
Prognostic Value of Novel Biomarkers on Adverse Renal Outcomes in High-Risk Cardiac Surgery Patients
trial testing Standard care "bundle" in Cardiac Surgery Associated - Acute Kidney Injury in 1,491 participants. Currently enrolling.
31 December 2028
Quick facts
| Lead sponsor | Guowei Tu |
|---|---|
| Status | Recruiting now |
| Study type | OBSERVATIONAL |
| Enrollment | 1,491 |
| Start date | 23 February 2026 |
| Primary completion | 31 December 2028 |
| Estimated completion | 31 May 2029 |
| Sites | 2 locations across China |
Drugs / interventions tested
- Standard care "bundle"
Conditions studied
- Cardiac Surgery Associated - Acute Kidney Injury — all drugs for Cardiac Surgery Associated - Acute Kidney Injury →
- Critical Illness — all drugs for Critical Illness →
Sponsor
Guowei Tu
Who can join
Adults 18 to 90, any sex, with Cardiac Surgery Associated - Acute Kidney Injury or Critical Illness. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This project aims to detect novel biomarkers from preoperative and early postoperative serum and urine samples of patients to screen and analyze the risk factors for predicting adverse postoperative renal outcomes in high-risk patients in cardiac surgery.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07418242
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Standard care "bundle"
Trials testing the same drug.
- NCT07521787 — Prognostic Value of Metabolic Characteristics in High-Risk Populations for Acute Kidney Injury After Cardiac Surgery · not yet recruiting
- NCT04962412 — Predicting Poor Outcomes of Cardiac Surgery-Associated Acute Kidney Injury Using Novel Biomarkers · completed
Other recruiting trials for Cardiac Surgery Associated - Acute Kidney Injury
Currently open trials in the same condition.
- NCT06705855 — A Comparison of Renal vs Limb NIRS for Predicting Cardiac Surgery Associated Acute Kidney Injury · recruiting
- NCT06811805 — Post-Marketing Study to Assess the Safety & Efficacy of RenalGuard® Therapy for Prevention CSA-AKI · NA · active not recruiting
Other Guowei Tu trials
Trials by the same sponsor.
- NCT04962945 — Comparison of the Oblique-axis and Long-axis Approaches for Axillary Vein Catheterization Under Ultrasound Guidance · NA · unknown
- NCT04962412 — Predicting Poor Outcomes of Cardiac Surgery-Associated Acute Kidney Injury Using Novel Biomarkers · completed
- NCT04953247 — Use of Compromised Lung Volume in Monitoring Usage of Steroid Therapy on Severe COVID-19 · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07418242 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Guowei Tu
- Last refreshed: 24 February 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07418242.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing